Naproxen 750 mg tablets(CR) bulk supplier for pharma manufacturers

Naproxen 750 mg Tablets(CR) 375 mg, 500 mg, 750 mg Suppliers & Bulk Manufacturers

Available Forms: CR tablets

Available Strengths: 375 mg, 500 mg, 750 mg

Reference Brands: Naprelan(US)

Category: Arthritis

Naproxen CR tablets inhibit cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin production, which alleviates pain and inflammation. The controlled-release formulation provides long-lasting effects, reducing dosing frequency. Benefits include sustained relief from arthritis pain, inflammation, and fever, with improved compliance and a reliable safety profile when used as directed.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Naproxen 750 mg Tablets(CR)? List it or send an offer →

Product Description:

Naproxen CR (Controlled Release) tablets are approved in the EU and US for pain, inflammation, and rheumatoid arthritis. In the EU, brands like Naprelan are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data, with generic versions available. Both regions require detailed dossiers for initial approval and ongoing pharmacovigilance. We support efficient market access for naproxen CR tablets, ensuring adherence to European and American standards for safe, effective anti-inflammatory therapy.

Naproxen 750 mg Tablets(CR) — third party manufacturing & bulk supply

Naproxen 750 mg Tablets(CR) 375 mg, 500 mg, 750 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Naproxen 750 mg Tablets(CR) is supplied as CR tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Naproxen 750 mg Tablets(CR) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Naproxen 750 mg Tablets(CR) →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Naproxen is used to relieve pain, reduce inflammation, and manage conditions such as arthritis, muscle pain, menstrual cramps, tendonitis, and other musculoskeletal disorders. It can also help reduce fever.

Naproxen contains naproxen sodium, a non-steroidal anti-inflammatory drug (NSAID). It works by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, which reduces the production of prostaglandins responsible for pain, inflammation, and fever.

Common trade names include Aleve, Naprosyn, Flanax, Napas, and Naprox.

Naproxen is manufactured by several pharmaceutical companies worldwide. Other manufacturers, including some in India, also make it. Tell us your market and we will match you with suitable licensed makers.

The generic name is Naproxen sodium.

Common brand names include Aleve, Naprosyn, Flanax, Napas, and Naprox.

Naproxen is manufactured in GMP-certified pharmaceutical facilities in countries such as India, Germany, the United States, and other global hubs by both innovator and generic pharmaceutical companies.